Caricamento...
The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease
Vedolizumab is a humanized monoclonal α4β7 integrin antibody used in patients with Crohn’s disease (CD) and ulcerative colitis (UC). Limited data are available on the use of vedolizumab in patients with concurrent cirrhosis and inflammatory bowel disease (IBD). Patients with cirrhosis are unique, as...
Salvato in:
| Pubblicato in: | Cureus |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cureus
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168050/ https://ncbi.nlm.nih.gov/pubmed/30305988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3080 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|